Compositions and methods for inhibition of HAO1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression

MY210704AActive Publication Date: 2025-10-08ALNYLAM PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2020004951
Authority / Receiving Office
MY · MY
Patent Type
Patents
Current Assignee / Owner
Priority Date
2015-09-04
Filing Date
2015-10-09
Publication Date
2025-10-08
Estimated Expiration
2035-10-09
Patent Text Reader

Abstract

The invention relates to RNAi agents, e.g., double-stranded RNAi agents, targeting the HAO1 gene, and methods of using such RNAi agents to inhibit expression of HAO1 and methods of treating subjects having, e.g., PH1. Described herein are double-stranded RNAi agents which inhibit the expression of a HA01 gene in a cell, such as a cell within a subject, e.g., a mammal, such as a human having a HAO1 associated disorder, and uses of such double-stranded RNAi agents. In certain aspects of the invention, substantially all of the nucleotides of an iRNA of the invention are modified.
Need to check novelty before this filing date? Find Prior Art